Debt-to-equity of ATOSSA THERAPEUTICS, INC. from 30 Sep 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ATOSSA THERAPEUTICS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2015 to 30 Sep 2025.
  • ATOSSA THERAPEUTICS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 10%, a 56% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ATOSSA THERAPEUTICS, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 10% +4% +56% 30 Sep 2025
Q2 2025 9% +3% +55% 30 Jun 2025
Q1 2025 8% +3% +64% 31 Mar 2025
Q4 2024 7% +3% +89% 31 Dec 2024
Q3 2024 7% +3% +88% 30 Sep 2024
Q2 2024 6% +2% +72% 30 Jun 2024
Q1 2024 5% +1% +47% 31 Mar 2024
Q4 2023 4% +1% +29% 31 Dec 2023
Q3 2023 4% +1% +55% 30 Sep 2023
Q2 2023 3% +1% +61% 30 Jun 2023
Q1 2023 3% 31 Mar 2023
Q4 2022 3% 31 Dec 2022
Q3 2022 2% 30 Sep 2022
Q2 2022 2% 30 Jun 2022
Q4 2020 35% +27% +321% 31 Dec 2020
Q3 2020 13% +2% +15% 30 Sep 2020
Q2 2020 12% 30 Jun 2020
Q1 2020 9% 31 Mar 2020
Q4 2019 8% 31 Dec 2019
Q3 2019 12% 30 Sep 2019
Q4 2015 35% 31 Dec 2015
Q3 2015 30% 30 Sep 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.